A Novel Blood Proteomic Signature for Prostate Cancer

SIMPLE SUMMARY: Despite intensive research, effective tools for detection and monitoring of prostate cancer remain to be found. Prostate-specific antigen (PSA), commonly used in prostate cancer assessments, can lead to overdiagnosis and overtreatment of indolent disease. This highlights the need for...

Descripción completa

Detalles Bibliográficos
Autores principales: Muazzam, Ammara, Spick, Matt, Cexus, Olivier N. F., Geary, Bethany, Azhar, Fowz, Pandha, Hardev, Michael, Agnieszka, Reed, Rachel, Lennon, Sarah, Gethings, Lee A., Plumb, Robert S., Whetton, Anthony D., Geifman, Nophar, Townsend, Paul A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9954127/
https://www.ncbi.nlm.nih.gov/pubmed/36831393
http://dx.doi.org/10.3390/cancers15041051

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9954127/
https://www.ncbi.nlm.nih.gov/pubmed/36831393
http://dx.doi.org/10.3390/cancers15041051

Ejemplares similares